Cite
LBA29 Aspirin after standard adjuvant therapy for colorectal cancers (ASCOLT): An international, phase III, randomised, placebo-controlled trial.
MLA
Chia, J. W. K., et al. “LBA29 Aspirin after Standard Adjuvant Therapy for Colorectal Cancers (ASCOLT): An International, Phase III, Randomised, Placebo-Controlled Trial.” Annals of Oncology, vol. 34, Oct. 2023, p. S1269. EBSCOhost, https://doi.org/10.1016/j.annonc.2023.10.021.
APA
Chia, J. W. K., Segelov, E., Deng, Y., Wang, W., Ho, G. F., Sharma, A., Ding, K., Chen, G., Jeffery, G. M., Nott, L. M., Zielinski, R., Ahn, J. B., Chao, T.-Y., Yau, T., Nabilah, S., Gandhi, M., Rothwell, P., Simes, J., Ali, R., & Toh, H. C. (2023). LBA29 Aspirin after standard adjuvant therapy for colorectal cancers (ASCOLT): An international, phase III, randomised, placebo-controlled trial. Annals of Oncology, 34, S1269. https://doi.org/10.1016/j.annonc.2023.10.021
Chicago
Chia, J.W.K., E. Segelov, Y. Deng, W. Wang, G.F. Ho, A. Sharma, K. Ding, et al. 2023. “LBA29 Aspirin after Standard Adjuvant Therapy for Colorectal Cancers (ASCOLT): An International, Phase III, Randomised, Placebo-Controlled Trial.” Annals of Oncology 34 (October): S1269. doi:10.1016/j.annonc.2023.10.021.